BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Aug 08, 2011
 |  BC Week In Review  |  Company News  |  Deals

MorphoSys, Merck deal

MorphoSys' AbD Serotec research and diagnostic antibodies unit and Merck added rights to a 2005 deal granting the pharma rights to MorphoSys' HuCAL Gold...

Read the full 99 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >